World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 25 April 2022
Main ID:  NCT03374553
Date of registration: 12/12/2017
Prospective Registration: No
Primary sponsor: iSTAR Medical
Public title: MINIject 636 in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications
Scientific title: A Prospective, Open, Multicentre Clinical Trial Analysing the Effectiveness and Safety of MINIject 636 in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications
Date of first enrolment: November 25, 2017
Target sample size: 52
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03374553
Study type:  Interventional
Study design:  Allocation: Non-Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Colombia India Panama
Contacts
Name:     Zubair Hussain, PhD
Address: 
Telephone:
Email:
Affiliation:  iSTAR Medical
Key inclusion & exclusion criteria

Inclusion Criteria:

- Diagnosis of primary or secondary open angle glaucoma during screening/baseline visit
or earlier.

- Grade 3 (open, 20-35 degrees) or grade 4 (wide open, 35-45 degrees) according to
Shaffer Angle Grading System.

- Glaucoma not adequately controlled

Exclusion Criteria:

- Diagnosis of glaucoma other than open angle glaucoma

- Grade 2, grade 1 and grade 0 according to Shaffer Angle Grading System.

- Neovascular glaucoma in the study eye

- Prior glaucoma surgery in the study eye

- Clinically significant corneal disease

- Patients with poor vision



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Open Angle Glaucoma
Intervention(s)
Device: MINI DO636
Device: MINI SO636
Primary Outcome(s)
Reduction in medicated diurnal IOP [Time Frame: 6 months after surgery]
Secondary Outcome(s)
Secondary ID(s)
ISM05
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history